CN Patent

CN121057582A — 抑制了前列腺素F2α衍生物的含有率降低的产品

Assigned to Mcpp Innovation Co ltd · Expires 2025-12-02 · 0y expired

What this patent protects

本发明的技术问题在于提供一种用于保存含有容易吸附于容器的前列腺素F2α衍生物的水性液剂的容器、及包含该水性液剂与该容器的产品。通过将含有前列腺素F2α衍生物的水性液剂保存于包含特定的环状聚烯烃的热塑性树脂容器，由此解决该技术问题。

USPTO Abstract

本发明的技术问题在于提供一种用于保存含有容易吸附于容器的前列腺素F2α衍生物的水性液剂的容器、及包含该水性液剂与该容器的产品。通过将含有前列腺素F2α衍生物的水性液剂保存于包含特定的环状聚烯烃的热塑性树脂容器，由此解决该技术问题。

Drugs covered by this patent

Patent Metadata

Patent number: CN121057582A
Jurisdiction: CN
Classification: —
Expires: 2025-12-02
Drug substance claim: No
Drug product claim: No
Assignee: Mcpp Innovation Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.